Hims Hers Health Inc Market Cap ($5.78 Billion)
Market Cap & Net Worth: Hims Hers Health Inc (HIMS)
Hims Hers Health Inc market cap. Hims Hers Health Inc (NYSE:HIMS) has a market capitalization of $5.78 Billion ($5.78 Billion) as of November 4, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #3146 globally and #1138 in its home market, demonstrating a -6.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hims Hers Health Inc's stock price $25.70 by its total outstanding shares 224935790 (224.94 Million). Also see HIMS operating cash flow for how efficiently the company converts equity into cash flow.
Hims Hers Health Inc Market Cap History (2019–2026)
Hims Hers Health Inc market cap history from 2019 to 2026. Data shows growth from $2.23 Billion to $5.78 Billion (14.45% CAGR). Check Hims Hers Health Inc stock quote for real-time trading data and today's change.
Index Memberships
Hims Hers Health Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.35 Trillion | 0.20% | #240 of 401 |
Weight: Hims Hers Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Hims Hers Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hims Hers Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore HIMS net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.11x
Hims Hers Health Inc's market cap is 3.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
56.90x
Hims Hers Health Inc's market cap is 56.90 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.23 Billion | $82.56 Million | -$72.06 Million | 26.97x | N/A |
| 2020 | $3.28 Billion | $148.76 Million | -$18.11 Million | 22.08x | N/A |
| 2021 | $1.47 Billion | $271.88 Million | -$107.66 Million | 5.42x | N/A |
| 2022 | $1.44 Billion | $526.92 Million | -$65.68 Million | 2.74x | N/A |
| 2023 | $2.00 Billion | $872.00 Million | -$23.55 Million | 2.30x | N/A |
| 2024 | $5.44 Billion | $1.48 Billion | $126.04 Million | 3.68x | 43.15x |
| 2025 | $7.30 Billion | $2.35 Billion | $128.37 Million | 3.11x | 56.90x |
Competitor Companies of HIMS by Market Capitalization
Companies near Hims Hers Health Inc in the global market cap rankings as of November 4, 2026. Also see Hims Hers Health Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Hims Hers Health Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Hims Hers Health Inc (2019–2026)
Market capitalization of Hims Hers Health Inc from 2019 to today. Between 2019 and today, Hims Hers Health Inc's market cap moved from $2.23 Billion to $ 5.78 Billion, with a yearly change of 14.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.78 Billion | -20.85% |
| 2025 | $7.30 Billion | +34.28% |
| 2024 | $5.44 Billion | +171.69% |
| 2023 | $2.00 Billion | +38.85% |
| 2022 | $1.44 Billion | -2.14% |
| 2021 | $1.47 Billion | -55.14% |
| 2020 | $3.28 Billion | +47.47% |
| 2019 | $2.23 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Hims Hers Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.78 Billion USD |
| MoneyControl | $5.78 Billion USD |
| MarketWatch | $5.78 Billion USD |
| marketcap.company | $5.78 Billion USD |
| Reuters | $5.78 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available … Read more